Mode VC
Amy Schulman

Amy Schulman

Managing Partner atPolaris PartnersMassachusetts
Full bioFirm profile

Amy Schulman is a managing partner at Polaris Partners focusing on healthcare and early-stage biotech investments. She joined in 2014, co-founded the Polaris Innovation Fund in 2017, and serves on multiple boards.

What Amy can write

Writes checks of$500K to $10M
Comes in atSeed, Series AMostly follows a lead
Best routeA warm introAsk a founder in their portfolio.

Polaris Partners writes $500K to $10M checks, larger than 71% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Polaris Partners.

Career

  1. DLA Piper · partner
  2. Pfizer · general counsel, president of Pfizer Nutrition and Pfizer Consumer Healthcare
  3. Polaris Partners · managing partner
    Now
  4. Harvard Business School · Senior Lecturer
    2014-present
  5. Cleary Gottlieb Steen & Hamilton
    1991
  6. Pfizer · general counsel
  7. Pfizer Nutrition · president
  8. Pfizer Consumer Healthcare · president

Companies founded

Polaris Innovation Fund

Investments named in public bios

Alnylam PharmaceuticalsElevance HealthQurAlisLarkspur

Focus

healthcareearly stage biotechbiotech

Education

Wesleyan University, Phi Beta Kappa graduateYale Law School

Also at Polaris Partners

Alexandra Cantley
Alexandra CantleyManaging Partner
Brian Chee
Brian CheeManaging Partner
Ellie McGuire
Ellie McGuireManaging Partner
Jon Flint
Jon FlintFounding Partner
Terry McGuire
Terry McGuireFounding Partner
Chen-Ee Lee
Chen-Ee LeePartner
Nil Gural
Nil GuralPrincipal
Manik Kuchroo
Manik KuchrooSenior Associate

Partners like Amy

At firms with a similar stage, sector and check size.

Ann DeWitt
Ann DeWittGeneral Partner, The Engine
Alexander Harstrick
Alexander HarstrickManaging Partner, Co-Founder, J2 Ventures
Anna FrenchManaging Partner, Qiming Venture Partners USA
Erica Murdock
Erica MurdockManaging Partner, Seae Ventures
Jim Vaughan
Jim VaughanManaging Principal & Co-Founder, VCapital
Stephen Knight
Stephen KnightSenior Managing Partner, F-Prime Capital

Alert me when Polaris Partners is active

One email when Amy's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Amy Schulman?

Amy Schulman is a managing partner at Polaris Partners focusing on healthcare and early-stage biotech investments. She joined in 2014, co-founded the Polaris Innovation Fund in 2017, and serves on multiple boards.

How much does Amy Schulman invest?

Amy Schulman invests through Polaris Partners, which writes checks of $500K to $10M at seed, series a.

How do I pitch Amy Schulman?

A warm intro from a founder Polaris Partners backed works best.

What did Amy Schulman do before Polaris Partners?

partner at DLA Piper; general counsel, president of Pfizer Nutrition and Pfizer Consumer Healthcare at Pfizer; Senior Lecturer at Harvard Business School; Cleary Gottlieb Steen & Hamilton; general counsel at Pfizer; president at Pfizer Nutrition; president at Pfizer Consumer Healthcare.

Last updated 2026-10-15. Is this you? Ask for a correction.